Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

We are delighted to present the latest edition of touchREVIEWS in Oncology & Haematology. This issue underscores the evolving landscape of cancer therapeutics, showcasing advances across a wide range of malignancies, from haematologic diseases to solid tumours, through novel mechanisms, emerging biomarkers and personalized treatment strategies. We begin with an editorial by Isabela Wen-Chi Chang […]

Eleni Andreopoulou, ASCO 2018 – Advances in molecular therapy in triple-negative breast cancer

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 8th 2018

Editorial board member, Eleni Andreopoulou, from Weill Cornell Medical College in New York, US, discusses molecular subtyping and advances in molecularly-targeted therapy in triple-negative breast cancer.

Q1. What are the major challenges of treating triple-negative breast cancer? (0:11)

Q2. How have advances in molecular subtyping impacted on the treatment of triple negative-breast cancer? (1:50)

Q3. What unmet needs remain in molecularly targeted breast cancer therapy? (2:36)

Q4. What innovations in clinical trial design are facilitating the development of therapies for high-risk, early-stage breast cancer? (3:41)

Speaker disclosures: Eleni Andreopoulou has nothing to disclose in relation to this video interview.

Filmed at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018, Chicago, IL, US, June 1–5 2018

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup